Socinski MA - Search Results

1

Evidence-based medicine in the treatment of non-small-cell lung cancer.

Reif MS, Socinski MA, Rivera MP. Reif MS, et al. Among authors: socinski ma. Clin Chest Med. 2000 Mar;21(1):107-20, ix. doi: 10.1016/s0272-5231(05)70011-3. Clin Chest Med. 2000. PMID: 10763093 Review.

2

Neoadjuvant treatment of stage IIIA non-small cell lung cancer. Long-term results.

Elias AD, Skarin AT, Gonin R, Oliynyk P, Stomper PC, O'Hara C, Socinski MA, Sheldon T, Maggs P, Frei E 3rd. Elias AD, et al. Among authors: socinski ma. Am J Clin Oncol. 1994 Feb;17(1):26-36. doi: 10.1097/00000421-199402000-00007. Am J Clin Oncol. 1994. PMID: 8311004 Clinical Trial.

3

Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.

Socinski MA, Detterbeck FC, Rivera MP, Egan TM, Halle J, Rosenman J. Socinski MA, et al. N C Med J. 1996 Sep-Oct;57(5):281-6. N C Med J. 1996. PMID: 8854691 Review. No abstract available.

4

IIB or not IIB: the current question in staging non-small cell lung cancer.

Detterbeck FC, Socinski MA. Detterbeck FC, et al. Among authors: socinski ma. Chest. 1997 Jul;112(1):229-34. doi: 10.1378/chest.112.1.229. Chest. 1997. PMID: 9228381 Review.

5

High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.

Socinski MA, Shea TC. Socinski MA, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-45-S12-51. Semin Oncol. 1997. PMID: 9331121 Review.

6

Induction therapy with carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal radiotherapy in the treatment of locally advanced, unresectable non-small cell lung cancer: preliminary report of a phase I trial.

Socinski MA, Clark JA, Halle J, Steagall A, Kaluzny B, Rosenman JG. Socinski MA, et al. Semin Oncol. 1997 Aug;24(4 Suppl 12):S12-117-S12-122. Semin Oncol. 1997. PMID: 9331135 Clinical Trial.

7

Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: pathologic and prognostic correlations.

Vargas SO, Leslie KO, Vacek PM, Socinski MA, Weaver DL. Vargas SO, et al. Among authors: socinski ma. Cancer. 1998 Apr 15;82(8):1495-500. Cancer. 1998. PMID: 9554526

8

Phase I trial of a 96 h paclitaxel infusion with filgrastim support in refractory solid tumor patients.

Socinski MA, Mudd PN Jr, Radomski KM, Steagall A, Lawrence P, Bernard S, Letrent SP, Gonzalez P, Brouwer KL. Socinski MA, et al. Anticancer Drugs. 1998 Aug;9(7):611-9. doi: 10.1097/00001813-199808000-00006. Anticancer Drugs. 1998. PMID: 9773805 Clinical Trial.

9

Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial.

Socinski MA, Steagall A, Gillenwater H. Socinski MA, et al. Cancer Invest. 1999;17(3):181-8. doi: 10.3109/07357909909021419. Cancer Invest. 1999. PMID: 10099656 Clinical Trial.

10

Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know.

George S, Schell MJ, Detterbeck FC, Socinski MA. George S, et al. Among authors: socinski ma. Oncologist. 1998;3(1):35-44. Oncologist. 1998. PMID: 10388082

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results